Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Loading
Home›
Research›
Investment Firms›
Excell Partners
AddedMar 19, 2024
UpdatedJul 1, 2026
Excell Partners

Excell Partners

Operating

Rochester-based software company, Excell Technology Ventures, a spinoff of Excell Partners.

Location
Rochester, NY, US
Founded
2005
Firm
Compare
Portfolio
Employees
News
Website

Investments

Ognomy Sleep
Ognomy Sleep
Series A

Total Raised

$22.8M

Rounds

3

Series A$20MJune 2026
Thread
Thread

Total Raised

$19.8M

Rounds

5

Series A$15MOctober 2023
Owl Autonomous Imaging
Owl Autonomous Imaging

Total Raised

$16.2M

Rounds

7

Series A$15MJanuary 2022
SunDensity
SunDensity

Total Raised

$22.7M

Rounds

9

Series UnknownDecember 2021
Conamix
Conamix

Total Raised

$14.5M

Rounds

4

Series Unknown$4MNovember 2021
SeedJuly 2016
Karma Water
Karma Water

Total Raised

$221.7k

Rounds

2

Seed$221.7kNovember 2020
Casana
Casana

Total Raised

$56.3M

Rounds

6

Seed$2.2MApril 2020
WexEnergy
WexEnergy

Total Raised

$1.4M

Rounds

5

Pre-Seed$450kMarch 2020
Pre-Seed$105kMarch 2018
VPG Medical
VPG Medical

Total Raised

$1.9M

Rounds

5

Series Unknown$25kFebruary 2020
Adarza BioSystems
Adarza BioSystems

Total Raised

$64.2M

Rounds

9

Series D$25MFebruary 2020
Ekostinger
Ekostinger

Total Raised

$2.7M

Rounds

9

Series Unknown$600kSeptember 2019
SeedJanuary 2018
Rialto Markets
Rialto Markets

Total Raised

$5M

Rounds

4

SeedJanuary 2019
Glauconix Biosciences
Glauconix Biosciences

Total Raised

$2.2M

Rounds

5

Seed$100kMay 2018
Gryt Health
Gryt Health

Total Raised

$5.3M

Rounds

4

Seed$840kMarch 2017
Tencar
Tencar
Seed

Total Raised

$125k

Rounds

3

Seed$100kJanuary 2017
SelfArray
SelfArray

Total Raised

$1.4M

Rounds

3

SeedJanuary 2017
Traverse Biosciences
Traverse Biosciences

Total Raised

$600k

Rounds

2

Seed$500kJune 2016
Sensor Films
Sensor Films

Total Raised

$2.5M

Rounds

2

Series Unknown$2.5MMarch 2016
Construction Robotics
Construction Robotics

Total Raised

$1.7M

Rounds

4

Series UnknownJanuary 2016
Pharmapotheca A
Pharmapotheca A

Total Raised

$2.5M

Rounds

2

SeedJanuary 2015
Molecular Glasses
Molecular Glasses

Total Raised

$225k

Rounds

2

SeedJanuary 2015
Efferent Labs
Efferent Labs

Total Raised

$900k

Rounds

2

Seed$500kOctober 2014